La catena delle opzioni mostra i dati chiave delle opzioni azionarie di SmileDirectClub a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per SmileDirectClub..

SmileDirectClub (OTC:SDCCQ) Azioni, Catena delle Opzioni

SmileDirectClub Inc is engaged in the orthodontics business. It is mainly involved in the sale of aligners, impression kits, whitening gel, and retainers. The company has one operating segment, aligner products.

WIIM

BTCS

BTCS shares are trading higher after the company announced its strategic intent to raise $100 million in 2025 to acquire Ethereum.

Barclays analyst Terry Ma maintains Fidelity National Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) with a Equal-Weight and lowers the price target from $67 to $65.

News

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Fidelity National Finl, Lowers Price Target to $65

FICO

Fair Isaac shares are trading lower after FHFA director Pulte said Fannie and Freddie will allow lenders to use Vantage 4.0 Score with no current requirement to build new infrastructure.

<a href="https://www.bloomberg.com/news/articles/2025-07-08/openai-microsoft-back-new-academy-to-bring-ai-into-classrooms?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-08/openai-microsoft-back-new-academy-to-bring-ai-into-classrooms?embedded-checkout=true</a>

General

MSFT

'OpenAI, Microsoft Back New Academy to Bring AI Into Classrooms'- Bloomberg

Barclays analyst Terence Malone maintains Essent Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESNT#NYSE">ESNT</a>) with a Equal-Weight and raises the price target from $58 to $59.

ESNT

Barclays Maintains Equal-Weight on Essent Group, Raises Price Target to $59

<a href="https://frontofficesports.com/obbba-gambling-tax-hike-trump-repeal/" title="https://frontofficesports.com/obbba-gambling-tax-hike-trump-repeal/">https://frontofficesports.com/obbba-gambling-tax-hike-trump-repeal/</a>

DKNG

FLUT

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

PENN

WYNN

'Bipartisan Effort Mounts to Repeal Gambling Tax Hike in Trump Bill' - Front Office Sports

Piper Sandler analyst Stephen Scouten upgrades Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) from Neutral to Overweight and raises the price target from $36 to $42.

Upgrades

CADE

Piper Sandler Upgrades Cadence Bank to Overweight, Raises Price Target to $42

WW International, Inc. (WeightWatchers) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) announced on Tuesday&nbsp;the successful completion of its strategic reorganization process.
WeightWatchers implemented a financial reorganization transaction in May to strengthen its financial position and increase investment flexibility. The company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45239193/weightwatchers-takes-strategic-action-to-eliminate-1-15-billion-of-debt-strengthening-financial-po" rel="noreferrer noopener">eliminated $1.15 billion in debt</a>.
With this improved financial foundation, the company is well equipped to execute its transformation plan, which includes innovating its digital and member experience and accelerating the expansion of <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">its telehealth business</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/45073094/weightwatchers-integrates-with-eli-lilly-to-expand-access-to-zepbound-stock-skyrockets-110" rel="noreferrer noopener">WeightWatchers Integrates With Eli Lilly To Expand Access To Zepbound, Stock Skyrockets 110%</a>
The company said in a press release in May that the business delivered 57% year-over-year revenue growth in the first quarter of 2025.
As part of this accelerated transformation, WeightWatchers made key leadership appointments. In its SEC <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/105319/000119312525156416/d83528dex991.htm" rel="noreferrer noopener">filing</a> on Tuesday, WeightWatchers said it appointed Dr.&nbsp;Kim Boyd as Chief Medical Officer to lead the company&#8217;s clinical vision, program development, and the integration of science into solutions for members.
&#8220;This is a pivotal moment for WeightWatchers,&#8221; said Tara Comonte, Chief Executive Officer of WeightWatchers. &#8220;With renewed financial strength, an expanded leadership team, and the addition of Dr.&nbsp;Boyd to lead clinical strategy and program innovation, we&#8217;re accelerating our transformation.&#8221;
Looking ahead, WeightWatchers will launch a new program later this year to support women through perimenopause, menopause, and postmenopause.
The offering builds upon WeightWatchers&#8217; existing program by delivering tailored nutritional and behavioral strategies with access to specialized clinical care, coaching, and community. The expansion into women&#8217;s health is a strategic move to address a broader gap in healthcare.
In addition to Dr. Boyd&#8217;s appointment, WeightWatchers has appointed Uta Knablein as Chief Product Officer to lead product strategy across the company&#8217;s expanding weight health platform.
As part of WeightWatchers&#8217; reorganization, a new Board of Directors will guide the company through its next growth phase.
Earlier in July, WeightWatchers announced an <a target="_blank" href="https://corporate.ww.com/news/news-details/2025/WeightWatchers-and-Novo-Nordisk-Expand-Collaboration-to-Improve-Medication-Access-Through-Trusted-Holistic-Model-of-Care/default.aspx" rel="noreferrer noopener">expanded</a> collaboration with Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>), which includes increased access to authentic, FDA-approved Wegovy (semaglutide) injection through WeightWatchers Clinic.
Additionally, Novo Nordisk is offering a limited-time savings offer available to WeightWatchers Clinic members. Starting July 1, 2025, eligible cash-pay members can access Wegovy at a reduced price of $299 until&nbsp;July 31, 2025.
In April, WeightWatchers announced a pharmacy integration with Eli Lilly and Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) LillyDirect <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g45066438/weightwatchers-streamlines-member-access-to-zepbound-vials-with-lillydirect-pharmacy-provider" rel="noreferrer noopener">pharmacy provider</a>, Gifthealth.
The integration will streamline access to Lilly&#8217;s FDA-approved Zepbound (tirzepatide) single-dose vials for WeightWatchers Clinic members with an on-label prescription from their clinician.
The integration will streamline access to Zepbound by offering a vial format for eligible Zepbound self-pay patients without insurance coverage.
Gifthealth will fulfill on-label prescriptions for Zepbound vials written by board-certified clinicians. WeightWatchers members will receive real-time Rx tracking directly within the WeightWatchers App.
Price Action: WW stock is trading higher by 2.75% to $41.10 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/07/46298240/voo-gets-some-love-as-investors-say-no-thanks-to-magnificent-7-stocks" target="_blank" rel="noreferrer noopener">VOO Gets Some Love As Investors Say &#8216;No Thanks&#8217; To Magnificent 7 Stocks</a></li>
</ul>
Photo by shisu_ka via Shutterstock

Health Care

Movers

WeightWatchers Sheds $1.15 Billion In Debt To Fuel Transformation

Trading Ideas

PROK

ProKidney Corp. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 422.7%

Growing up in a trailer park with parents <a href="https://www.benzinga.com/personal-finance/25/02/43578779/warren-buffett-said-anybody-whos-willing-to-work-40-hours-a-week-deserves-a-decent-life-but-proposes-a-minimum-income-not-minimum-wage-2">working minimum wage jobs</a>, this millennial didn't have a college degree, inheritance or a financial safety net. What they did have was a job at 16, the drive to keep moving, and two decades of relentless effort that broke the cycle of poverty in their family.
<h2 class="wp-block-heading">Retail, Relocation And Relentless Work</h2>
"My parents both worked min wage jobs. We lived paycheck to Tuesday with nothing," they wrote in a Reddit <a href="https://www.reddit.com/r/povertyfinance/comments/1lr56o3/how_i_escaped_generational_poverty/">post</a> that quickly gained traction in r/povertyfinance. "Yes, I grew up in a trailer park."
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Starting at 16 in retail, they <a href="https://www.benzinga.com/personal-finance/management/25/07/46261660/a-couple-share-how-they-went-from-living-in-their-car-to-a-1-million-net-worth-i-managed-to-find-a-low-paying-but-stable-job">climbed the ladder</a> through sheer effort—first shift manager, then assistant, and by 25, a store manager &#8220;for a smallish-sized clothing company,&#8221; earning $45,000 a year in 2010. That job, they said, was the first real win. Then came a pivotal moment: the death of their mother and a chance to move out of state.
"I had nothing tying me down here," they recalled. "I was renting a room in an apartment." That freedom opened the door to a $75,000 retail job in another state in 2019, despite starting at a &#8220;sh&#x2A;t store.&#8221;
They worked the numbers, improved the store&#8217;s performance, and were soon recruited again, this time into human resources and benefits. They took a pay match in a lower role, gained employer-funded certifications, and now earn $125,000 plus bonuses in a fully remote position.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">&#8220;It Wasn't Glorious&#8221;</h2>
"It wasn't glorious. I worked a ton of nights, weekends and holidays. I missed functions, events, and so forth," they wrote. Now 38, married, and a homeowner with a <a href="https://www.benzinga.com/money/best-401k-funds-for-investment">well-funded 401(k)</a>, they say the sacrifice was worth it. "My son will never have to endure my struggles, but he is being taught the value of a dollar."
They added, "So the answer is retail, sacrifice 20 years of your life and move around. Not the best answer but it worked for me. And I only have a high school diploma."
<h2 class="wp-block-heading">No One Waiting To Catch Them</h2>
Many commenters shared similar stories of long hours, relocating for opportunity, and learning to let go of toxic family ties. For the original poster, moving wasn't just about career growth. "I found when I moved, I moved on from my old life. And I never looked back," they said.
Others pointed out how difficult that route has become. &#8220;Retail has tanked majorly since 2010,&#8221; one person wrote. Others stressed that fast food chains don't always pay enough or offer full hours anymore.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Still, the OP acknowledged that luck plays a role. "As I have gotten older, these thoughts are what haunt me," they said, referring to the fragility of financial security. But they added they now carry disability and life insurance, and live frugally: "We cut our own grass and do our own oil changes. I still have a poor person buying mentality."
<h2 class="wp-block-heading">Building Better For The Next Generation</h2>
Today, they're focused on setting their son up to avoid the same hardship. "He will be <a href="https://www.benzinga.com/money/should-you-add-child-as-authorized-user-credit-card">added as an [authorized user]</a> to my credit cards to get him a strong score," they wrote. He gets paid for chores and grades, and may start college classes in high school through dual enrollment.
They added, "I'm gonna show him [our relatives&#8217;] mugshots and street views of the sh&#x2A;t holes they live in."
The overall message is that it&#8217;s about grit, not glamor. Long nights, not shortcuts. And above all, moving forward, sometimes literally, is the first step to climbing out.
Read Next: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</a>
Image: Shutterstock

Personal Finance

No Degree, No Inheritance, No Safety Net—Just Grit. This Millennial Escaped Generational Poverty And Wants Others To Know They Can Too

Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) has outperformed the market over the past 5 years by 10.29% on an annualized basis producing an average annual return of 24.81%. Currently, Uber Technologies has a market capitalization of $200.90 billion. 
Buying $100 In UBER: If an investor had bought $100 of UBER stock 5 years ago, it would be worth $289.89 today based on a price of $96.90 for UBER at the time of writing.
<h3>Uber Technologies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751989513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

UBER

Here's How Much You Would Have Made Owning Uber Technologies Stock In The Last 5 Years

IonQ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares climbed above $47.85 Tuesday morning before pulling back. The stock is still up approximately 13.5% over the past month. Here&#8217;s a look at what&#8217;s driving the <a href="https://www.benzinga.com/quote/IONQ">recent price action</a>.
What To Know: IonQ shares got a boost in early June after the company <a href="https://www.benzinga.com/node/45848184">announced results</a> of a collaborative research program with AstraZeneca, Amazon Web Services and Nvidia to develop and demonstrate a quantum-accelerated computational chemistry workflow.
IonQ said the collaboration led to a more than 20-fold boost in speed over traditional approaches to early-stage drug development. By combining IonQ's quantum hardware with AWS and Nvidia platforms, the team cut processing time down from months to just days.
<a href="https://www.benzinga.com/node/45889749">IonQ and other</a> quantum stocks also got a lift following bullish comments from Nvidia CEO Jensen Huang at Nvidia's GTC developer conference in Paris. The Nvidia CEO said quantum computers were &#8220;reaching an inflection point&#8221; and could start solving &#8220;interesting problems&#8221; in the next few years. Several quantum stocks rallied on the bullish commentary from Huang. 
In late June, IonQ <a href="https://www.benzinga.com/node/46175752">gained momentum after</a> the Texas Legislature passed HB 4751 — the Texas Quantum Initiative. The bill aims to make Texas a major hub for quantum innovation. IonQ said the bill establishes a structure to tap into the state&#8217;s academic and tech industries by offering investment incentives and research opportunities.
On Monday, IonQ shares held up well despite announcing the pricing of a $1 billion equity offering, with shares and pre-funded warrants sold at $55.49 each, or about 25% above the stock's July 3 closing price.
IonQ has a consensus price target of $41.43, according to Benzinga <a href="https://www.benzinga.com/quote/IONQ/analyst-ratings">analyst data</a>. A couple of analysts have weighed in on the stock in July, including Benchmark analyst David Williams, who maintained a Buy and raised the target from $50 to $55, and Cantor Fitzgerald analyst Troy Jensen, who initiated coverage with an Overweight rating and set a price target of $45.
IONQ Price Action: At the time of publication, IonQ shares were down 0.25% at $45.08, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwjIuf6GvK2OAxUVlYkEHTmaHD4QFnoECBAQAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>. The stock traded as high as $47.88 on Tuesday before pulling back. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46297630/lucid-just-drove-749-miles-without-charging-and-set-a-world-record">Lucid Just Drove 749 Miles Without Charging And Set A World Record</a></li>
</ul>
Image via Shutterstock

IONQ

What's Behind The Recent Rally In IonQ Stock?

ProKidney Corp. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 386.4%

In a move that could reshape the landscape of clean energy, President Donald Trump's recent signing of the "<a href="https://www.benzinga.com/markets/tech/25/07/46270052/as-trumps-big-beautiful-bill-is-signed-into-law-these-evs-from-tesla-gm-and-ford-will-become-more-expensive">One Big Beautiful Bill</a>" extends a lifeline to hydrogen production, offering a vital two-year grace period for companies eager to invest in this burgeoning sector.
The law allows the 45V <a href="https://www.benzinga.com/topic/renewable-energy">clean hydrogen production</a> tax credit to be available for projects that commence construction on hydrogen facilities by Dec. 31, 2027, an extension of 2 years vs. the prior draft's deadline, according to JPMorgan.
The Plug Power Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5aabc09cb023000001cb8b57/bill-peterson">Analyst Bill Peterson</a> reiterated a Neutral rating on Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>).
The Plug Power Thesis: The company now has more flexibility to deploy capital rather than having to rush due to a closer cutoff, Peterson said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
"The preservation of direct pay and transferability make the credits monetizable and should help continue to offset some of Plug's cash burn," he wrote.
Plug Power had delayed the plant in Texas due to uncertainties around the tax credit, the analyst stated. With this resolved, the company "can make meaningful progress with the DOE (Department of Energy) on the loan draw," he added.
Given the DOE's broader financing facility, Plug Power could construct the new plant by 2026-2027 "subject to appropriate equity financing in conjunction," Peterson further said.
PLUG Price Action: Shares of Plug Power had risen by 3.6% to $1.42 at the time of publication on Tuesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/content/46264488/how-a-government-loan-changes-the-game-for-plug-power">How a Government Loan Changes the Game for Plug Power</a></li>
</ul>
Photo by T. Schneider via Shutterstock

Analyst Color

Reiteration

PLUG

Trump's Hydrogen Lifeline Could Revive Plug Power's Stalled Plans

JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Overweight and lowers the price target from $350 to $330.

UTHR

JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $330

Morgan Stanley analyst Ronald Kamdem maintains VICI Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>) with a Equal-Weight and raises the price target from $33 to $35.

VICI

Morgan Stanley Maintains Equal-Weight on VICI Properties, Raises Price Target to $35

SMLR

Semler Scientific shares are trading higher after Benchmark initiated coverage on the stock with a Buy rating and announced a price target of $101.

Morgan Stanley analyst Brian Morton maintains Smurfit WestRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) with a Overweight and raises the price target from $51 to $53.

Morgan Stanley Maintains Overweight on Smurfit WestRock, Raises Price Target to $53

MAZE

Maze Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $17.

Wolfe Research analyst George Notter initiates coverage on Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) with a Underperform rating.

Comments

SmileDirectClub

SmileDirectClub (SDCCQ) Opzioni

SmileDirectClub (OTC:SDCCQ) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO